Physician profile
Jonathan Barnes
NPI 1891270385
$5,469.58
in general payments reported to CMS, 2019-2025
32 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,818 · 2022: $1,306 · 2023: $1,176 · 2024: $675 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,346.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $535.32 | 2021-2024 | |
| Medtronic, INC. | $489.95 | 2021-2025 | Symplicity G3, Linq II, Corevalve Evolut R |
| Astrazeneca Pharmaceuticals Lp | $467.59 | 2021-2024 | Andexxa, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $431.44 | 2021-2024 | Lifevest |
| Abbott Laboratories | $335.44 | 2023-2025 | Navitor, Cardiomems, Jot Dx |
| Impulse Dynamics (USA) INC. | $313.90 | 2022-2024 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $287.06 | 2021-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $285.73 | 2021-2023 | Xarelto |
| Novo Nordisk INC | $257.79 | 2021-2024 | Ozempic |
| Amgen INC. | $257.17 | 2021-2024 | Repatha |
| Amarin Pharma, INC. | $242.84 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.74 | 2021-2024 | Jardiance |
| Kiniksa Pharmaceuticals, Ltd. | $195.97 | 2021-2023 | Arcalyst |
| Cvrx, INC. | $190.11 | 2021-2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $183.17 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $135.22 | 2021-2024 | |
| Genzyme Corporation | $106.37 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $87.20 | 2021-2022 | |
| Philips North America LLC | $75.31 | 2022-2023 | |
| Pfizer INC. | $53.84 | 2021-2023 | |
| Chiesi USA, INC. | $43.55 | 2023 | Kengreal |
| Akcea Therapeutics, INC. | $41.19 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $38.43 | 2021 | |
| Boston Scientific Corporation | $36.99 | 2022-2024 | Lux-Dx Insertable Cardiac Monitor |
| Inari Medical, INC. | $35.18 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Arbor Pharmaceuticals, INC. | $32.15 | 2021-2022 | |
| Cardiva Medical, INC. | $25.58 | 2023 | Cardiva Vascade 6/7f Vcs |
| Irhythm Technologies, INC. | $21.29 | 2023 | Zio Xt Patch |
| Cardiovascular Systems INC. | $20.07 | 2021 | |
| Zoll Circulation INC | $18.82 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Actelion Pharmaceuticals US, INC. | $11.28 | 2021 | |
| Itamar Medical INC | $7.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.